Nuvectis Pharma, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $31.7M
Liabilities Breakdown FY2025
Total Liabilities: $13.3M
Asset Breakdown
Total Assets: $31.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $31.6M | 99.8% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $75.0K | 0.2% |
Liabilities Breakdown
Total Liabilities: $13.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $6.3M | 47.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $7.0M | 52.8% |